| Name | Title | Contact Details |
|---|
Oliver-Tolas Healthcare Packaging is one of the world's leading producers of sterile-grade medical device packaging and pharmaceutical packaging. Oliver-Tolas brings together the best of Oliver Medical Packaging and Tolas Healthcare Packaging's 30+ years producing the industry's highest quality and most innovative products.
Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.
The West Wireless Health Institute is one of the first medical research organizations in the world supporting the exploration and application of wireless technologies to advance infrastructure independent health care.
C3 Industries is led by a passionate, creative, and hardworking team of cannabis cultivation and processing experts. We produce the highest quality, indoor cannabis flower and extracted products at our state-of-the-art facilities in Oregon and Michigan.
EndoStim is a medical device company focused on the treatment of gastroesophageal reflux disease (GERD) through electrical stimulation of the lower esophageal sphincter. GERD is a condition affects millions of people worldwide and is often not optimally treated despite a maximum drug dosage of medications such as proton pump inhibitors (PPIs). EndoStim’s innovative technology provides a solution addressing the root physiological cause of the disease -- namely a weak or dysfunctional lower esophageal sphincter that allows for reflux into the esophagus.